Tenderwize
Back to tender search

Open house Umeclidiniumbromid discount agreements

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Mar 05, 2027 · 200 days left·Open·Supplies·Framework
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Umeclidiniumbromid, ATC R03BB07

60/100

Opportunity Score

PromisingLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

60 / 100

Complexity

20 / 100

Risk factors

Agreements are non-exclusive and can be terminated automatically if a competitive discount contract is concluded for th...

No estimated value provided; potential revenue is uncertain.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Strong opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Apr 2027
  • Provision of Umeclidiniumbromid (ATC R03BB07) pharmaceutical products
  • Conclusion of a non-exclusive discount agreement under §130a Abs. 8 SGB V
Show full summary

This is an Open-House model (not a public procurement procedure) by AOK Bayern to conclude non-exclusive discount agreements for the active substance Umeclidiniumbromid (ATC R03BB07) with all interested pharmaceutical companies that meet the eligibility criteria. Contracts run from 01.05.2025 to 30.04.2027. Joining is possible until 05.03.2027. No competitive selection; any eligible company can join. Estimated value is not provided. Performance is in Bavaria, Germany.

Risks

Agreements are non-exclusive and can be terminated automatically if a competitive discount contract is concluded for th...

No estimated value provided; potential revenue is uncertain.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Eligibility

  • Only pharmaceutical companies are eligible to participate

Administrative

  • Submission of a signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit)
  • Submission of a signed contract agreement including annex 'Festlegung der vertragsgegenständlichen Arzneimittel'

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open house Umeclidiniumbromid discount agreements

Non-exclusive discount agreements for Umeclidiniumbromid (ATC R03BB07). All pharmaceutical companies that meet the eligibility criteria can join. Contracts are identical and non-negotiable. Duration: 01.05.2025 - 30.04.2027. Automatic termination if a national or regional discount contract is concluded via a competitive procedure.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Apr 2025 - Apr 2027

Category

Pharmaceutical products

Deadline

Deadline Mar 05, 2027

Procurement Details

Publication date
18 Mar 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
178944-2025

Documents (2)

Similar tenders